Krish Patel, MD, Swedish Cancer Institute, Seattle, WA
Recorded on June 6, 2024
Krish Patel, MD
Director, Lymphoma Program
Director, Hematologic Malignancies and Cellular Therapy
Swedish Cancer Institute
Seattle, WA
Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on mantle cell lymphoma today!
Podden och tillhörande omslagsbild på den här sidan tillhör The Leukemia & Lymphoma Society. Innehållet i podden är skapat av The Leukemia & Lymphoma Society och inte av, eller tillsammans med, Poddtoppen.
